This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Forendo Pharma Oy

Drug Names(s): 17ß-HSD1 inhibitor, 17ß-hydroxysteroid-dehydrogenase isoform 1 inhibitor, HM-102

Description: This compound is an inhibitor of 17ß-hydroxysteroid dehydrogenase isoform 1 (17ß-HSD1), an enzyme responsible for catalyzing the final step in the conversion of estrone to estradiol.

Deal Structure: Forendo and Hormos
In June 2013, Forendo announced that it has acquired from Hormos Medical the drug development programs for endometriosis (17-HSD) and male low testosterone (fispemifene).

FP-5677 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug